CDBIO(SH:688739) Sou Hu Cai Jing·2025-08-05 21:48Summary of Key Points Core Viewpoint - Chengda Biological Co., Ltd. has announced its share repurchase plan, which is aimed at employee stock ownership plans or equity incentives, but as of July 31, 2025, the company has not yet implemented this plan [1][3]. Trading Information - On August 5, 2025, Chengda Biological's stock closed at 28.58 yuan, with a slight increase of 0.28% - The trading volume was 21,900 shares, resulting in a total transaction value of 62.5655 million yuan - The net inflow of main funds was 2.6507 million yuan, accounting for 4.24% of the total transaction value - Retail investors had a net inflow of 702,900 yuan, representing 1.12% of the total transaction value, while speculative funds saw a net outflow of 3.3536 million yuan, making up 5.36% of the total transaction value [1][3]. Company Announcement - The share repurchase plan was first disclosed on June 19, 2025, with an implementation period from June 19, 2025, to June 18, 2026 - The expected repurchase amount is between 10 million yuan and 20 million yuan - The repurchase price will not exceed 38.00 yuan per share - As of July 31, 2025, the company has not repurchased any shares, with a total repurchase amount of 0 yuan and a shareholding proportion of 0% - The company will disclose the progress of the repurchase plan within the first three trading days of each month during the repurchase period [1].